Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Turner

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Medical Internet Research|October 26, 2014
Patients' continuing use of an online health record: a quantitative evaluation of 14,000 patient years of access dataRichard G Phelps, Joanne Taylor, Keith Simpson, et al.
European Journal of Endocrinology|September 8, 2012
Increasing use of radioiodine in young people with thyrotoxicosis in Great BritainNeil Turner, Ian Driver, Jane A Salotti, et al.
Nephrology (Carlton, Vic.)|July 21, 2016
Simultaneous adult polycystic kidney disease and Alport syndromePaul J Phelan, Elaine Fletcher, Nicola Carroll, et al.
Journal of the American Society of Nephrology : JASN|February 9, 2007
Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopesJuan Zou, Lorna Henderson, Vicky Thomas, et al.
F1000Research|December 3, 2015
Following specific podocyte injury captopril protects against progressive long term renal damageYu S Zhou, Ihmoda A Ihmoda, Richard G Phelps, et al.
CEN Case Reports|May 17, 2017
Propylthiouracil-associated rapidly progressive crescentic glomerulonephritis with double positive anti-glomerular basement membrane and antineutrophil cytoplasmic antibody: the first case reportPitchaporn Kantachuvesiri, Panas Chalermsanyakorn, Bunyong Phakdeekitcharoen, et al.
The Journal of Biological Chemistry|February 13, 2007
The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domainJeong Suk Kang, Clifford E Kashtan, A Neil Turner, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2008
Healthy individuals have Goodpasture autoantigen-reactive T cellsJuan Zou, Sigrid Hannier, Lindsay S Cairns, et al.
Journal of the American Society of Nephrology : JASN|August 4, 2025
Authors' Reply: Questions Regarding the Analysis of Long-Term Outcomes in Nephrotic SyndromeDavid Pitcher, Bruce Hendry, Alex Mercer, et al.
Kidney International|January 14, 2004
Retransplantation in Alport post-transplant anti-GBM diseaseGemma Browne, Paul A J Brown, Charles R V Tomson, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Medical Internet Research|October 26, 2014
Patients' continuing use of an online health record: a quantitative evaluation of 14,000 patient years of access dataRichard G Phelps, Joanne Taylor, Keith Simpson, et al.
European Journal of Endocrinology|September 8, 2012
Increasing use of radioiodine in young people with thyrotoxicosis in Great BritainNeil Turner, Ian Driver, Jane A Salotti, et al.
Nephrology (Carlton, Vic.)|July 21, 2016
Simultaneous adult polycystic kidney disease and Alport syndromePaul J Phelan, Elaine Fletcher, Nicola Carroll, et al.
Journal of the American Society of Nephrology : JASN|February 9, 2007
Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopesJuan Zou, Lorna Henderson, Vicky Thomas, et al.
F1000Research|December 3, 2015
Following specific podocyte injury captopril protects against progressive long term renal damageYu S Zhou, Ihmoda A Ihmoda, Richard G Phelps, et al.
CEN Case Reports|May 17, 2017
Propylthiouracil-associated rapidly progressive crescentic glomerulonephritis with double positive anti-glomerular basement membrane and antineutrophil cytoplasmic antibody: the first case reportPitchaporn Kantachuvesiri, Panas Chalermsanyakorn, Bunyong Phakdeekitcharoen, et al.
The Journal of Biological Chemistry|February 13, 2007
The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domainJeong Suk Kang, Clifford E Kashtan, A Neil Turner, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2008
Healthy individuals have Goodpasture autoantigen-reactive T cellsJuan Zou, Sigrid Hannier, Lindsay S Cairns, et al.
Journal of the American Society of Nephrology : JASN|August 4, 2025
Authors' Reply: Questions Regarding the Analysis of Long-Term Outcomes in Nephrotic SyndromeDavid Pitcher, Bruce Hendry, Alex Mercer, et al.
Kidney International|January 14, 2004
Retransplantation in Alport post-transplant anti-GBM diseaseGemma Browne, Paul A J Brown, Charles R V Tomson, et al.
Pageof 4